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Summary
Methionine sulphoxide reductases (Msr) catalyse the
reduction of oxidized methionine to methionine.
These enzymes are divided into two classes, MsrA
and MsrB, according to substrate speciﬁcity.
Although most MsrA and MsrB exist as separate
enzymes, in some bacteria these two enzymes are
fused to form a single polypeptide (MsrAB). Here, we
report the ﬁrst crystal structure of MsrAB from Strep-
tococcus pneumoniae (SpMsrAB) at 2.4 Å resolution.
SpMsrAB consists of an N-terminal MsrA domain, a
C-terminal MsrB domain and a linker. The linker is
composed of 13 residues and contains one 310-helix
and several hydrogen bonds interacting with both
MsrA and MsrB domains. Interestingly, our structure
includes the MsrB domain complexed with an
SHMAEI hexa-peptide that is the N-terminal region of
neighbouring MsrA domain. A kinetic analysis
showed that the apparent Km of SpMsrAB for the
R-form-substrate was 20-fold lower than that for the
S-form substrate, indicating that the MsrB domain
had a much higher affinity for the substrate than the
MsrA domain. Our study reveals the ﬁrst structure of
the MsrAB by providing insights into the formation of
a disulphide bridge in the MsrB, the structure of the
linker region, and the distinct structural nature of
active site of each MsrA and MsrB domain.
Introduction
Methionine (Met) is one of the most oxidation-sensitive
amino acids. Oxidation of Met to methionine sulphoxide
(Met-SO) damages the proteins and can alter protein
function (Hoshi and Heinemann, 2001; Weissbach et al.,
2002; Moskovitz, 2005; Kim and Gladyshev, 2007).
However, these damaged proteins can be reversed by the
repair enzymes, methionine sulphoxide reductases (Msr).
Msr enzymes are essential to protect cells, such as
bacteria, mammals and plants, against oxidative stress
(Skaar et al., 2002; Alamuri and Maier, 2004; Bechtold
et al.,2004;Kantorowet al.,2004),andarealsoimplicated
in ageing and neurodegenerative diseases (Gabbita et al.,
1999; Moskovitz et al., 2001; Ruan et al., 2002; Friguet,
2006;Wassefet al.,2007).TwodistinctMsrenzymeshave
been classiﬁed for the reduction of Met-SO: MsrAreduces
the S-form of Met-SO and MsrB reduces the R-form (Brot
et al., 1981; Sharov and Schoneich, 2000; Grimaud et al.,
2001). MsrA and MsrB have their active sites that display
an essentially mirror-image-like relationship, reﬂecting the
observed stereo-speciﬁcity of these enzymes (Lowther
et al., 2002). The MsrA and MsrB sequences show no
homologytoeachother.However,enzymaticstudiesdem-
onstrate that both the enzymes share a common catalytic
mechanism based on sulphenic acid chemistry involving
two(orthree)cysteineresidues(Boschi-Mulleret al.,2000;
Kumar et al., 2002; Antoine et al., 2003; Olry et al., 2004;
Kauffmann et al., 2005).
Most organisms contain MsrA and MsrB typically as
separate enzymes. However, MsrA and MsrB exist as
domains in a single fused protein (MsrAB) in some bac-
teria such as Streptococcus pneumoniae, Neisseria gon-
orrhoeae and Haemophilus inﬂuenza (Kryukov et al.,
2002; Delaye et al., 2007). Why some bacteria possess
the fusion protein instead of separate MsrA and MsrB
forms is not clear. Analysis of the sequence alignment of
MsrA, MsrB and MsrAB reveals that the active sites are
conserved in each protein. To date, individual MsrA and
MsrB structures from eight species have been reported
(Lowther et al., 2000; 2002; Tête-Favier et al., 2000;
Taylor et al., 2003; Rouhier et al., 2007; Ranaivoson
et al., 2008) or deposited (1XM0, 3CXK and 3CEZ).
However, there is no structural information on MsrAB.
Compared with either the MsrA or MsrB structure, MsrAB
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exists between the MsrA and MsrB domains.
Inthisstudy,wereporttheﬁrstcrystalstructureofMsrAB
fromS. pneumoniae(SpMsrAB).TheSpMsrABconsistsof
an N-terminal MsrA domain (SpMsrA), a C-terminal MsrB
domain (SpMsrB) and a linker. The linker, iloop, contains
conserved residues that participate in signiﬁcant hydrogen
bondsperhapstomaintainstructuralstability.Interestingly,
our structure includes an SpMsrB complex with a hexa-
peptide (SHMAEI) that is the N-terminal region of neigh-
bouring SpMsrA through crystal packing. This is the ﬁrst
report of a complex form with a peptide including the
product Met in the active site of MsrB structure. Kinetic
analysis revealed that the apparent Km value of SpMsrAB
for Met-R-SO is 20-fold lower than that for Met-S-SO and
the catalytic efficiency (kcat/Km) for the R-form is sevenfold
higher than that for the S-form.
Results and discussion
Overall structure and comparison of SpMsrAB
The orthorhombic structure of SpMsrAB was determined
using the method of single-wavelength anomalous disper-
sion (SAD) to a resolution of 2.4 Å with seleno-Met.
Phasing and reﬁnement statistics are shown in Table 1.
Theasymmetricunitcontainsfourmoleculesthatshowtwo
conformations (Fig. 1A and Fig. S1). Molecule A (Mol A)
and molecule C (Mol C) are the same conformation (con-
formation 1) while molecule B (Mol B) and molecule D (Mol
D) are the other conformation (conformation 2). Interest-
ingly, Mol A contains an SHMAEI hexa-peptide and Mol B
and Mol C have an SHMA peptide in their MsrB domains,
butthereappearsnopeptideboundinMolD.Thisstructure
results from the crystal packing. Thus far, no MsrB struc-
tures in complex with a peptide substrate (or product) have
been reported. The SHMAEI hexa-peptide in Mol A was
donated from the symmetric Mol D molecule in the neigh-
bouring unit cell (Figs S1 and S2). The Ser and His are
originated from the His-tag following thrombin treatment
cleavage in the protein puriﬁcation. The Met, Ala, Glu and
Ile of the hexa-peptide are identical to the N-terminal
residues of the native SpMsrAB sequence. The molecules
donating SHMApeptides bound in Mol B and Mol C are not
clear.
The monomeric structure of SpMsrAB has the overall
dimensions of approximately 74.5 ¥ 37.5 ¥ 39.7 Å3 and
consists of two major domains, MsrA(residues 1–158) and
MsrB (residues 172–312), and a linker domain (residues
159–171) (Fig. 1B). The N-terminal SpMsrA and
C-terminal SpMsrB domains are structurally similar to the
Table 1. Data collection and reﬁnement statistics.
SpMsrAB
SeMet-peak Native
Data collection
Space group P21212P 2 1212
Cell dimension, a, b, c (Å) 158.8 165.0 77.9 158.5 165.5 77.3
Molecules per AU 4 4
Wavelength (Å) 0.97950 1.00000
Resolution range (Å) 20.0–2.70 (2.80–2.70) 20.0–2.4 (2.48–2.40)
No. of measured reﬂections 1 533 200 1 036 517
No. of unique reﬂections 55 599 90 336
Completeness (%) 99.6 (98.8) 91.9 (77.5)
Average I/s(I) 26.9 (3.5) 9.3 (1.3)
Rmerge
a (%) 11.1 (36.8) 10.5 (46.5)
Reﬁnement
Resolution range (Å) 20.0–2.7 20.0–2.4
No. of reﬂections (work/test) 56 761 (51 027/5734) 77 162 (70 101/7061)
Rwork
b/Rfree
c 22.2/28.6 23.9/28.2
B-factors (Å
2) (protein/solvent) 44.0/38.0 47.3/50.4
No. of atoms (protein/ligand/water) 10 088/92/413 10 104/107/305
Root mean square deviations
Bond lengths (Å) 0.008 0.007
Bond angles (degree) 1.3 1.4
Ramachandran plot
Most favoured (%) 82.9 87.3
Additionally allowed (%) 16.6 12.6
Generously allowed (%) 0.5 0.1
Disallowed (%) 0.1 0.0
a. Rmerge =S hSj|〈I〉h - Ihj|/ShSj|Ihj, where 〈I〉h is the mean intensity of symmetry-equivalent reﬂections.
b. Rwork =S h|Fo - Fc|/Sh|Fo|, where Fo and Fc are the observed and calculated structure factor amplitudes of reﬂection h.
c. Rfree is the same as Rwork, but calculated on the reﬂections set aside from reﬁnement.
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respectively. The N-terminal MsrA domain of SpMsrAB is
composed of eight rolled mixed b-strands (b1–b8) and
seven a-helices (a1–a7), similar to Bos taurus MsrA
(BtMsrA) (Lowther et al., 2000), Escherichia coli MsrA
(EcMsrA) (Tête-Favier et al., 2000), Mycobacterium tuber-
culosisMsrA(MtMsrA)(Tayloret al.,2003),Neisseriamen-
ingitides MsrA (NmMsrA) (Ranaivoson et al., 2008) and
Populus trichocarpa MsrA (PtMsrA) (Rouhier et al., 2007)
(Fig. 2A). The MsrB domain of SpMsrAB is composed of
seven antiparallel b-strands (b9–b16) and seven a-helices
(a9–a15), similar to the structures of MsrB from N. gonor-
rhoeae (NgMsrB) (Lowther et al., 2002), Burkholderia
pseudomallei (BpMsrB; 3CEZ, 3CXK) and Bacillus subtilis
(BsMsrB; 1XM0). We also determined the crystal structure
of BsMsrB (3E0O) for comparison of SpMsrB (Fig. S3 and
Table S1; Park et al., 2008). It should be noted that the
crystal structures of BpMsrB (3CEZ, 3CXK) and the NMR
structure of BsMsrB (1XM0) had not been reported when
we initiated this study. Our crystal structure of BsMsrB was
foundtobeidenticaltotheNMRBsMsrBstructureandwas
further used for structure comparison. Comparison of
SpMsrB with BpMsrB, BsMsrB and NgMsrB revealed that
SpMsrBismorehighlyconservedthanSpMsrA(Fig. 2B).A
sequence alignment analysis indicated that SpMsrAB
shows a high sequence identity to other bacterial MsrABs:
Fig. 1. Overall structures of SpMsrAB.
A. In the crystallographic orthorhombic form, four molecules of SpMsrAB show two conformations in an asymmetric unit. Mol A and Mol C are
the same conformation while Mol B and Mol D are the other conformation. SHMAEI and SHMA peptides are shown by stick models. The
SHMAEI hexa-peptide in Mol A is originated from the N-terminal region of Mol D in the neighbouring unit cell. The molecules that donate the
SHMA in Mol B and Mol C are not clear.
B. Ribbon diagram of the structure of the SpMsrAB–SHMAEI hexa-peptide complex, with individual elements of secondary structure labelled.
All ﬁgures were created using the PYMOL (http://pymol.sourceforge.net/) (left). Topology diagram of SpMsrAB was drawn with TOPS (Westhead
et al., 1999). a-Helices (circles) are labelled a1–a15 and b-strand (triangles) are labelled b1–b16 (right).
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(to Helicobacter pylori) and 59% (to H. inﬂuenza) (Fig. 3).
These bacterial MsrABs are linked by a hinge region;
NgMsrAB and NmMsrAB contain additional 12 residues in
their linker regions compared with those of other species.
However, the role of the linker in MsrABs is not known.The
linker, iloop,o fSpMsrAB consists of 13 residues (residues
159–171) and, interestingly, contains one 310-helix and
several hydrogen bonds to both the MsrA and MsrB
domains that could restrict the positions of both domains.
Structural positions of critical cysteines in catalysis
in SpMsrAB
Cys-10 and Cys-284 are charged for catalytic attack of
Met-S-SO and Met-R-SO respectively. Cys-150 and Cys-
229 (called recycling cysteines) interact with the oxidized
catalytic cysteines (sulphenic acid intermediates), respec-
tively, to form disulphide bonds. Cys-10 and Cys-150 of
SpMsrA were compared with those of EcMsrA, BtMsrA,
MtMsrA, PtMsrA and NmMsrA (Fig. 4A). The structural
positions of Cys-10 and Cys-150 were similar to those of
other MsrAs. As expected from the structures of EcMsrA,
BtMsrA, MtMsrA and PtMsrA, the catalytic Cys-10 of
SpMsrA is remote from the recycling Cys-150 which
is located within the ﬂexible loop (residues 145–153).
The distances between the two cysteine residues are
8.0 Å (SpMsrA), 8.6 Å (BtMsrA), 12.8 Å (EcMsrA), 6.8 Å
(MtMsrA) and 7.1 Å (PtMsrA). To form a disulphide bridge,
the two catalytic and recycling cysteine residues in such a
long distance may undergo conformational changes that
bring the residues within approximately 3.0 Å of each
other, as shown in the structure of NmMsrA (Ranaivoson
et al., 2008). As shown in Fig. 4B, unlike SpMsrA, the
catalytic Cys-284 and recycling Cys-229 of SpMsrB are
structurally identical to those of the NgMsrB, BpMsrB and
Fig. 2. Structural comparison of MsrAs and
MsrBs.
A. Comparison of MsrAs. The backbone
models for E. coli, Bos taurus, Mycobacterium
tuberculosis, Neisseria meningitides (3BQH),
Popular trichocarpa and Streptococcus
pneumoniae are shown in green, red, yellow,
orange, cyan and blue respectively.
B. Comparison of MsrBs. The backbone
models for Bacillus subtilis, Neisseria
gonorrhoaea, Burkholderia pseudomallei
(3CXK) and S. pneumoniae are shown in
orange, green, yellow and blue respectively.
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229 is sufficient to enable formation of a disulphide bridge.
To form a disulphide bridge, the b-carbon (Cb) of Cys-284
must rotate towards the substrate Met-R-SO and the
angle of the Ca of Cys-229 must change. These obser-
vations suggest that MsrB can easily form a disulphide
bridge once the protein binds a substrate.
Complex formation with the SHMAEI hexa-peptide of
SpMsrAB
Most MsrAstructures contain a complex with either a small
molecule such as dithiothreitol, mercaptoethanol and
arsenate group (Lowther et al., 2000; Tête-Favier et al.,
2000; Rouhier et al., 2007), or a Met residue through a
Fig. 3. Multiple sequence alignment of MsrABs. Multiple sequence alignment of HpMsrAB, HiMsrAB, NmMsrAB, NgMsrAB and SpMsrAB is
shown (Hi, Haemophilus inﬂuenza; Hp, Helicobacter pylori; Nm, Neisseria meningitides; Ng, Neisseria gonorrhoae). Sequence alignment was
accomplished with BioEdit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). In the sequence alignment, red and blue box indicate the catalytic
and recycling cysteine residues respectively; yellow and cyan box indicate the conserved residues participating in the catalytic mechanisms of
MsrA and MsrB respectively. The linker region is shown in green box and Asp-156 and Lys-159 are shown as an inverted red triangle.
Fig. 4. Structural positions of active-site cysteine residues.
A. The positions of cysteines in SpMsrA. The catalytic Cys-10 and recycling Cys-150 are labelled. The stick models for the active-site amino
acids for EcMsrA (green), BtMsrA (red), MtMsrA (yellow), NmMsrA (orange), PtMsrA (cyan) and SpMsrA (blue) are superimposed. For
NmMsrA (3BQH), the approximate position of unresolved sequence was added and connected with the dotted line.
B. The positions of cysteines in SpMsrB. The catalytic Cys-284 and recycling Cys-229 are labelled. The stick models for the active-site amino
acids for BsMsrB (red), NgMsrB (cyan), BpMsrB (green; 3CXK) and SpMsrB (yellow) are superimposed.
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substrate (3BQF) (Ranaivoson et al., 2008) in their active
pocket. NgMsrB structure also includes a cacodylate mol-
ecule in its active site (Lowther et al., 2002). Interestingly,
as mentioned, our SpMsrAB structure reveals a complex
between the active pocket of SpMsrB and the SHMAEI
hexa-peptide, and is the ﬁrst report of the structure of an
MsrB complex with the product Met. The hexa-peptide is
surrounded by four loops, A, B, C and D (Fig. 5A). The
structure of the SpMsrB complex indicates that the cata-
lytic Cys-284 faces the sulphur atom of the Met residue.
His-269 and one water molecule also interact with the
sulphur atom of the Met residue. Thr-192, His-266 and
Asn-286 are stabilized by their interaction with water
(Fig. 5B). The Thr-192, His-266, His-269 and Asn-286
havebeenproposedtobeimportantforMsrBcatalysisand
these residues are well conserved in all MsrBs. The struc-
turally ordered water molecule, which interacts with Thr-
192,Asn-286andMet-SOduringtheenzymaticreaction,is
also suggested to play a key role in the enzymatic reaction
of MsrB as shown in the structure of NgMsrB (Lowther
et al., 2002). Our complex structure with the SHMAEI
peptide supports the catalytic mechanism model of MsrB
proposed earlier (Lowther et al., 2002).
Similar to the general structural features of the MsrBs,
the structure of SpMsrB demonstrates that the active
site is exposed to solvent and that its substrate, Met-R-
SO, can readily form a complex with the enzyme. The
active-site pocket of SpMsrA is negatively charged while
that of SpMsrB is positively charged, similar to the previ-
ously known MsrA and MsrB structures. These opposite
charge distributions in the substrate binding pockets of
SpMsrA and SpMsrB may contribute to a factor for dis-
criminating their stereo-speciﬁc substrates, Met-S-SO and
Met-R-SO, in which the positions of oxygen of the sul-
phoxide moiety are different from each other. Unlike
SpMsrB, the residues forming the active-site pocket in
SpMsrA are so bulky that the steric hindrance may be
produced from the aromatic ring structures of Phe-11,
Trp-12 and Tyr-91 when a substrate attempts to access
the active pocket (Fig. 6A). Despite no signiﬁcant confor-
mational changes between the reduced NmMsrA (3BQE)
and the complexed form with a Met-SO substrate (3BQF)
(Ranaivoson et al., 2008), the ﬂanked loop, including b4
and b5, of the active pocket appears to be somewhat
different between these two forms (Fig. S4). It is more
‘open’ state in the reduced form than in the complexed
form. This ﬂanked loop of the SpMsrA was more ‘closed’
state than those of the complexed NmMsrA and MtMsrA
forms (Fig. S4). Taken together, the results suggest the
‘closed’ nature of the MsrAactive site relative to the ‘open’
MsrB active site in SpMsrAB. However, there is a possi-
bility that the crystal contacts and packing of the four
molecules within the crystal lattice may have preferentially
stabilized the ‘closed’ state of active site of SpMsrA
domain.
As described above, the formation of the product Met–
SpMsrB complex is correlated to the kinetics of SpMsrAB.
The surface model of SpMsrB demonstrates that the
SHMAEI hexa-peptide ﬁts within the active-site pocket
(Fig. 6B). Based on these results, we propose a structural
model for the disulphide bridge formation in MsrB
(Fig. 6C). When SpMsrB accesses Met-R-SO, (i) the cata-
lytic Cys-284 attacks the sulphur atom of Met-R-SO and
Fig. 5. The SpMsrB–SHMAEI complex.
A. A complex structure of the SpMsrB–SHMAEI hexa-peptide. Four loops that surround the SHMAEI hexa-peptide are shown in surface model
and the SHMAEI hexa-peptide is shown by 2Fo - Fc electron density map at 1.0 s.
B. Interaction in the SpMsrB–SHMAEI hexa-peptide complex. The detail interaction between the Met of SHMAEI hexa-peptide and the
active-site residues of SpMsrB is displayed. The water molecule is shown as a red sphere. The residues involving the interactions are shown
in stick models. The Met residue is shown as a green stick model.
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product Met is released, the Cb angle of Cys-284 rotates
towards the recycling Cys-229, (iii) the Cys-229 also
moves towards the Cys-284 and (iv) a disulphide bridge
forms between these residues. Finally, the oxidized MsrB
is associated with thioredoxin to reduce the disulphide
bond.
Speciﬁc activity and kinetic analysis
The speciﬁc activities and kinetic parameters of
SpMsrAB and BsMsrB are summarized in Table 2.
HPLC for kinetic analysis and the preparation of dabsyl-
Met-R-SO and dabsyl-Met-S-SO were conducted
according to established procedures (Minetti et al., 1994;
Kumar et al., 2002; Etienne et al., 2003). The MsrB
activity of SpMsrAB was slightly higher than its MsrA
activity at 200 mM substrate. However, the apparent kcat
value for dabsyl-Met-R-SO was threefold lower than that
for dabsyl-Met-S-SO. The total Msr activity was consis-
tent with the sum of the MsrA and MsrB activities. The
speciﬁc MsrA and MsrB activities of SpMsrAB were
similar to those of mammalian MsrA and MsrB (Kim
and Gladyshev, 2004; Kim and Gladyshev, 2005). The
speciﬁc activity of BsMsrB was slightly lower than the
MsrB activity of SpMsrAB and of mammalian MsrBs. Km
values of SpMsrAB were 0.86 mM for dabsyl-Met-S-SO
and 0.038 mM for dabsyl-Met-R-SO. These data suggest
that SpMsrAB can efficiently catalyse the Met-R-SO to
Met reaction at low substrate concentrations. BsMsrB
also has a low Km value, similar to that of SpMsrAB for
dabsyl-Met-R-SO. The catalytic efficiency (kcat/Km)o f
Fig. 6. Surface models of active pockets of MsrA and MsrB domains and MsrB catalytic mechanism model.
A. A surface model of SpMsrA active pocket. The stick models of residues (except Cys-10 and Cys-150) show the steric hindrance produced
when a substrate attempts to access the pocket of SpMsrA. The active pocket is negatively charged.
B. A surface model showing the SpMsrB complex. The green stick model is the SHMAEI hexa-peptide and the blue stick models are the
residues that interact with the hexa-peptide. The active pocket is positively charged.
C. A model for MsrB catalytic mechanism. When MsrB accesses a substrate, catalytic Cys-284 attacks the sulphur atom of its substrate
(i.e. Met-R-SO) (a). Recycling Cys-229 and the oxidized Cys-284 (sulphenic acid form) change their positions (b) to establish a disulphide
bridge (c). A complete disulphide bridge is formed in SpMsrB (d). The model shows SpMsrB and the SHMAEI hexa-peptide. Cys-229 and
Cys-284 are shown in stick models (blue). The red stick model represents the shift of Cys-284 after MsrB attacks a substrate and the green
stick model is the SHMAEI hexa-peptide.
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that for dabsyl-Met-S-SO. These results suggest that the
MsrB domain contains a more efficient catalytic activity
than the MsrA domain in the bacterial MsrAB. Moreover,
the higher affinity for the R-form of the substrate
may have been correlated with the SpMsrB complex for-
mation with the SHMAEI hexa-peptide in the crystal
structure.
The linker region of SpMsrAB
SpMsrA and SpMsrB form a single protein joined by a
linker. Why some bacteria contain an MsrAB rather than
separate MsrA and MsrB is not clear, and raises a ques-
tion as to whether these two domains behave differently
in the fused protein. In this work, we ﬁrst demonstrated
the structure of MsrA–MsrB fusion protein including the
linker region (see also the electron density map of the
linker region in Fig. S5). Unexpectedly, two structural
conformations of SpMsrAB were revealed in an asym-
metric unit. We compared these two conformations and
found that SpMsrA occurs in two dramatically distinct
conformations relative to the centre of the iloop, while
SpMsrB forms a complex with Met (Fig. 7A). SpMsrB is
complexed with the SHMAEI hexa-peptide, and the
movement of SpMsrB is therefore restricted. In contrast,
SpMsrA may move over approximately 10 Å. As
described above, the hinge loop iloop, which connects
MsrA and MsrB, is composed of residues 159–171. The
movement of Lys-159 is remarkable in the two confor-
mations of the structure (Fig. 7B).
As mentioned, the iloop contains one 310-helix and
several hydrogen bonds interacting with residues at both
the MsrA and MsrB domains. The interacting hydrogen
bonds are summarized in Table 3. We also found changes
of hydrogen bonds between Msr domains and iloop in the
two conformations (Table 3). An outstanding change in
hydrogen bonds is a new bond formation between Asp-
156 of SpMsrA and Lys-159 of iloop in the conformation 2
(Fig. 7B). This interaction between Asp-156 and Lys-159
may induce (or result from) the distinct movement of
SpMsrA. These results suggest that the movement of
MsrA domain in other MsrABs may also occur while MsrB
domain movement may be restricted relative to the central
iloop, although the Asp-156 and Lys-159 of SpMsrAB are
not conserved in other MsrABs. According to the
sequence alignment, other MsrABs have Lys and Glu
residues in these positions (Fig. 3), but these two resi-
dues are likely to interact with each other as well. To verify
the role of these residues, further studies will be needed.
The linker of SpMsrAB may stabilize the positions of the
MsrA and MsrB domains relative to each other, despite
the fact that two distinct conformations are observed in an
asymmetric unit. In regard to the occurrence of two dra-
matically different MsrA conformations, the SpMsrA may
have another function in the cells in addition to the cata-
lytic function.
In summary, we determined the ﬁrst crystal structure of
SpMsrAB at 2.4 Å resolution. First, we suggest that the
iloop region of SpMsrAB may play a role in the structural
stability of the protein by hydrogen bond interactions with
both the MsrA and MsrB domains. Further biochemical
and structural studies will be necessary for verifying the
function of the iloop. Second, the apparent Km value of
SpMsrB for the substrate is 20-fold lower than that of
SpMsrA, suggesting that SpMsrB forms a complex with its
substrate more readily than SpMsrA. Third, in agreement
with this kinetic result, we demonstrate the ﬁrst structure
of MsrB complexed with Met residue. As a result of exam-
ining the SpMsrB–SHMAEI complex, we propose a model
for the catalytic mechanism of MsrB and this model shows
how catalytic and recycling cysteine residues are involved
in conformational changes to form a disulphide bridge.
The structural and subsequent biochemical analysis
reveals why SpMsrB can readily form a complex with its
substrate and provides insights into the distinct structural
nature of the active site of each MsrAand MsrB domain in
MsrAB family.
Table 2. Speciﬁc activities and kinetic parameters of SpMsrAB.
Protein Substrate
Speciﬁc activity
[nmol min
-1
(mg protein)
-1] Km (mM) kcat (s
-1) kcat/Km (M
-1 s
-1) Reference
S. pneumoniae MsrAB Met-S-SO 250  7 0.86  0.05 0.80  0.04 930  10 This study
Met-R-SO 327  3 0.038  0.002 0.24  0.01 6320  150
Met-R,S-SO 580  7N A N A N A
B. subtilis MsrB Met-R-SO 264  14 0.041  0.002 0.10  0.005 2440  70 This study
Mouse MsrA Met-S-SO 238  26 0.34  0.04 0.28  0.02 820  50 Kim and Gladyshev (2005)
Mouse MsrB2 Met-R-SO 353 0.17 0.23 1350 Kim and Gladyshev (2004)
Human MsrB3 Met-R-SO 423 2.9 2.29 790 Kim and Gladyshev (2004)
The speciﬁc activities and kinetic parameters were determined using dabsylated substrates as described in Experimental procedures.
NA, not assayed.
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Cloning, expression and protein puriﬁcation
The gene encoding the full-length SpMsrAB (residues 1–312)
was ampliﬁed from the S. pneumoniae genome by PCR. The
PCR products were then digested with BamHI and XhoI and
inserted into pET-28a (+) (Novagen), containing a His-tag.
The plasmid was transformed into E. coli BL21(DE3). Cells
were grown in LB medium and protein expression was
induced with 0.5 mM IPTG at 18°C. After induction, the cells
were harvested and disrupted by sonication in buffer A
[20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 5 mM imidazole
and 1 mM DTT]. The lysate was then clariﬁed by centrifuga-
tion and was applied to a 5 ml HisTrap column (Amersham
Pharmacia). The protein was eluted by linear gradient with
buffer A and 5–500 mM imidazole. The His-tag was removed
by treatment with thrombin, followed by dialysis overnight at
4°C. The protein was loaded on a 5 ml HiTrap ion exchange
column (Amersham Pharmacia) using buffer of 50 mM Tris-
HCl (pH 8.0) and 5 mM DTT with a gradient of 0–1.0 M NaCl
followed by gel ﬁltration on a HiLoad 26/60 Superdex-200
column (Amersham Pharmacia) using buffer of 25 mM Tris-
HCl (pH 8.0), 100 mM NaCl and 5 mM DTT. The puriﬁed pro-
tein was concentrated to 35 mg ml
-1. Seleno-Met-labelled
SpMsrAB was expressed in E. coli B834(DE3) and puriﬁed
as described above.
Crystallization and data collection
SpMsrAB crystals suitable for X-ray data collection were
grown by the hanging-drop vapour diffusion method at 22°C
in [0.1 M MES (pH 5.6), 1% (w/v) PEG 4000 and 0.2 M
Fig. 7. The movement of MsrA and the
hinge loop, iloop, motion of SpMsrAB.
A. Two conformations appeared in the
crystallographic asymmetric unit. The position
of SpMsrA moves approximately 10 Å. Con 1
and Con 2 show the distinct positions of the
SpMsrA domain in an asymmetric unit when
superposed by optimizing the linker regions of
two conformations. The blue is shown as a
conformation 1 (Con 1) and the white as a
conformation 2 (Con 2). The N- and
C-terminal of Con 2 is presented with N′ and
C′ respectively. The red box is a linker region.
The hexa-peptide SHMAEI from Con 1 is
shown in green stick model.
B. The interaction change of Lys-159 between
two conformations (Con 1 and Con 2).
Asp-156 and Lys-159 of Con 2 is presented
with Asp-156′ and Lys-159′ respectively. The
magenta is the linker region of Con 1 while
the white is the linker of Con 2. The amino
acids of linker region are shown as the stick
models.
Table 3. The hydrogen bonds and their changes between Msr
domains and iloop in the two conformations.
Hydrogen bond Conformation 1 Conformation 2
MsrA–iloop
Arg-65 (NH2)–Asp-163 (Od1) 2.9 Å 3.0 Å
Arg-65 (Ne)–Asp-163 (Od2) 2.5 Å 2.8 Å
Arg-73 (NH1)–Lys-159 (O) 2.8 Å 3.4 Å
Arg-73 (NH2)–Pro-160 (O) 3.2 Å 2.9 Å
Asp-156 (Od1)–Lys-159 (Nz) – 2.7 Å
iloop–MsrB
Ser-171 (Og)–Val-174 (Cg1) 2.9 Å 3.0 Å
Ser-171 (O)–Leu-175 (N) 3.2 Å 3.1 Å
Lys-169 (Nz)–Gln-188 (Oe1) 2.8 Å –
Tyr-167 (O)–Ser-262 (Og) 2.6 Å 2.6 Å
Ile-162 (O)–Arg-261 (Nh2) 2.9 Å 2.9 Å
Tyr-167 (OH)–Tyr-305 (OH) 2.9 Å 2.9 Å
–, none.
Crystal structure of MsrA–MsrB fusion protein 707
© 2009 The Authors
Journal compilation © 2009 Blackwell Publishing Ltd, Molecular Microbiology, 72, 699–709MgCl2]. For cryoprotection, the crystals were soaked in res-
ervoir solution containing 25% ethylene glycol and frozen in
cold nitrogen at -173°C. X-ray diffraction was performed at
beam line 4A of the Pohang Light Source (PLS), Pohang,
Korea. The ﬁnal X-ray diffraction data were collected with a
Quantum 210 CCD detector (Area Detector Systems, Poway,
CA). The native SpMsrAB crystal diffracted to 2.4 Å and
belongs to the space group P21212, with unit cell dimenhyqj-
sions: a = 158.5 Å, b = 165.5 Å and c = 77.3 Å. The SAD data
using seleno-Met-labelled SpMsrAB were collected at peak
wavelength (0.9795 Å). The data were processed and scaled
using HKL2000 (Otwinowski and Minor, 1997).
Structure determination and reﬁnement
The crystal structure of SpMsrAB was determined by the
SAD method. Searching of 12 selenium sites and calculation
of phase were carried out with the SOLVE (Terwilliger and
Berendzen, 1999; Terwilliger, 2000). The ﬁrst model was built
into 2.7 Å resolution electron density map by using Coot
(Emsley and Cowtan, 2004). After reﬁnement with CNS
(Brünger et al., 1998), the resolution was improved to 2.4 Å.
Final reﬁnement, after including a hexa-peptide and solvents,
resulted in R and Rfree values of 23.9% and 28.2% (for a 10%
data sample) respectively. Data collection and reﬁnement
statistics are summarized in Table 1. The atomic co-ordinates
and structure factors for the SpMsrAB have been deposited
in the Protein Data Bank with the accession code 3E0M. A
crystal structure of BsMsrB was also determined (Table S1;
Park et al., 2008) and has been deposited (3E0O). The
Protein Data Bank accession codes for other Msr proteins
discussed in this article are as follows: BtMsrA (1FVA),
EcMsrA (1FF3), MtMsrA (1NWA), NmMsrA (3BQE, 3BQF,
3BQH), PtMsrA (2J89), BsMsrB (1XM0), BpMsrB (3CEZ,
3CXK) and NgMsrB (1L1D).
Kinetic assays
MsrA and MsrB activities were determined in the presence of
DTT using dabsylated Met-SO as substrate. Brieﬂy, a 100 ml
reaction mixture contained a buffer of 50 mM sodium phos-
phate (pH 7.5), 50 mM NaCl and 20 mM DTT, and either
200 mM dabsyl-Met-S-SO (for MsrA assays) or dabsyl-Met-
R-SO (for MsrB assays), and 1 mg of puriﬁed protein of
SpMsrAB or BsMsrB. To assay for the total Msr activity of
SpMsrAB, 400 mM mixed (R, S) Met-SO was used. The reac-
tions were carried out at 37°C for 30 min and stopped by
adding 200 ml of acetonitrile. The dabsyl-Met product was
analysed using an HPLC procedure. Km and kcat values were
determined for DTT-dependent reactions from Lineweaver-
Burk plots. For determination of Km, 0.05–0.8 mM dabsyl-
Met-S-SO was used and 0.05–0.2 mM dabsyl-Met-R-SO was
used.
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